Loading...
XSHG600721
Market cap332mUSD
Jan 03, Last price  
6.36CNY
1D
-2.15%
1Q
-18.04%
Jan 2017
-65.73%
Name

Xinjiang Bai Hua Cun Co Ltd

Chart & Performance

D1W1MN
XSHG:600721 chart
P/E
187.84
P/S
6.60
EPS
0.03
Div Yield, %
0.00%
Shrs. gr., 5y
-1.08%
Rev. gr., 5y
-2.50%
Revenues
369m
+5.54%
119,277,36846,175,16652,846,48837,562,32039,089,94163,649,936696,564,2511,209,836,8881,118,869,8201,181,709,6961,108,870,132808,805,222744,574,204419,502,543419,189,442262,017,71884,530,414281,353,040349,884,562369,277,391
Net income
13m
001,283,0285,630,5316,703,01417,060,94741,038,76575,539,09420,465,3562,991,69700139,134,1570034,384,702059,827,132012,972,337
CFO
64m
+19.69%
95,661,1578,095,0036,480,98411,085,98712,251,0320339,112,920559,640,574342,002,9396,631,614202,160,848423,580,9520080,553,7170034,721,68353,177,02763,645,192
Dividend
May 22, 19970.0784 CNY/sh
Earnings
May 20, 2025

Profile

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021. Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd was founded in 1959 and is headquartered in Urumqi, China.
URL
http://www.xjbhc.net/
IPO date
Jun 26, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
369,277
5.54%
349,885
24.36%
Cost of revenue
272,298
270,761
Unusual Expense (Income)
NOPBT
96,979
79,124
NOPBT Margin
26.26%
22.61%
Operating Taxes
3,509
2,612
Tax Rate
3.62%
3.30%
NOPAT
93,470
76,512
Net income
12,972
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
505
Long-term debt
2,263
3,642
Deferred revenue
1,810
2,353
Other long-term liabilities
1,927
1,493
Net debt
(263,510)
(436,994)
Cash flow
Cash from operating activities
63,645
53,177
CAPEX
(17,239)
Cash from investing activities
(15,653)
Cash from financing activities
19,913
6,225
FCF
121,096
142,725
Balance
Cash
202,071
135,731
Long term investments
63,703
305,411
Excess cash
247,309
423,647
Stockholders' equity
381,693
446,378
Invested Capital
464,174
245,858
ROIC
26.33%
27.56%
ROCE
12.87%
11.16%
EV
Common stock shares outstanding
379,308
375,729
Price
7.74
26.06%
6.14
-18.02%
Market cap
2,935,845
27.26%
2,306,979
-17.89%
EV
2,672,334
1,869,984
EBITDA
122,018
105,282
EV/EBITDA
21.90
17.76
Interest
63
113
Interest/NOPBT
0.07%
0.14%